European Journal of Cancer Care

Editorial
pp. 213-213(1)

News
pp. 214-219(6)

Patients with head and neck cancer prefer individualized cognitive behavioural therapy
pp. 220-227(8)
Authors: Semple, C.J.; Dunwoody, L.; Sullivan, K.; Kernohan, W.G.

A scoring system for the assessment of oral mucositis in daily nursing practice
pp. 228-234(7)
Authors: POTTING, C.M.J.; BLIJLEVENS, N.A.M.; DONNELLY, J.P.; FEUTH, T.; VAN ACHTERBERG, T.

Refill adherence to repeat prescriptions of cancer drugs to ambulatory patients
pp. 235-237(3)
Authors: NILSSON, J.L.G.; ANDERSSON, K.; BERGKVIST, A.; BJÖRKMAN, I.; BRISMAR, A.; MOEN, J.

A clinical interview assessing cancer patients' spiritual needs and preferences
pp. 238-243(6)
Authors: FRICK, E.; RIEDNER, C.; FEGG, M.J.; HAUF, S.; BORASIO, G.D.

A qualitative study of anterior resection syndrome: the experiences of cancer survivors who have undergone resection surgery
pp. 244-251(8)
Authors: DeSnoo, L.; Faithfull, S.

Influence of cardiopulmonary resuscitation on levels of tumour markers
pp. 252-256(5)
Authors: BERENT, R.; AUER, J.; PORODKO, M.; LAMM, G.; WEBER, T.; WIMMER, E.; SEIER, J.; ASPÖCK, G.; EBER, B.

When legal worlds collide: from research to treatment in hereditary cancer prevention
pp. 257-266(10)
Author: TUPASELA, A.

Risk of colorectal cancer in general practice patients presenting with rectal bleeding, change in bowel habit or anaemia
pp. 267-271(5)
Authors: LAWRENSON, R.; LOGIE, J.; MARKS, C.

Lymphoma: variations in time to diagnosis and treatment
pp. 272-278(7)
Authors: HOWELL, D.A.; SMITH, A.G.; ROMAN, E.

What non-prescription treatments do UK women with breast cancer use?
pp. 279-285(7)
Authors: CATT, S.; FALLOWFIELD, L.; LANGRIDGE, C.

Analysis of clinical outcomes and prognostic factors of neoadjuvant chemoradiotherapy combined with surgery: intraperitoneal versus extraperitoneal rectal cancer
pp. 286-292(7)
Authors: BENZONI, E.; TERROSU, G.; BRESADOLA, V.; CERATO, F.; COJUTTI, A.; MILAN, E.; DADO, G.; BRESADOLA, F.

Quality of life in newly diagnosed patients with lung cancer in a developing country: is it important?
pp. 293-298(6)
Authors: MOHAN, A.; MOHAN, C.; BHUTANI, M.; PATHAK, A.K.; PAL, H.; DAS, C.; GULERIA, R.

Intravenous ibandronate does not affect time to renal function deterioration in patients with skeletal metastases from breast cancer: phase III trial results
pp. 299-302(4)
Authors: BODY, J.J.; DIEL, I.J.; TRIPATHY, D.; BERGSTROM, B.

Palliative care for intractable breathlessness in cancer
pp. 303-314(12)

Forthcoming events
pp. 315-315(1)